Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6097)	10/18/1998 3:04:00 PM
From: Anthony Wong	Respond to of 9523

10/18 08:05 Novartis <NOVZn.S> working on potency pill - paper ZURICH, Oct 18 (Reuters) - Swiss pharmaceuticals and nutrition group Novartis AG has begun a high priority research and development programme aimed at producing an anti-impotency drug to compete with Pfizer's <PFE.N> Viagra, a Swiss newspaper reported on Sunday. A Novartis spokeswoman declined comment on the report. "We don't comment on projects in pre-clinical phases," she said. But according to the report in the Sonntags Zeitung, the Novartis programme is aimed at producing a cheaper medication with fewer undesirable side effects. The newspaper said Paul Herrling, head of reseach at Novartis, confirmed that the company had plans in this area. But it said he declined to give details, saying such projects were still at a very early stage. According to the Novartis spokeswoman, Herrling had only confirmed that Novartis was working on projects in the so-called "lifestyle" or "wellness" areas. Lifestyle drugs are designed to improve patients' quality of life. The spokeswoman said Herrling made no reference to Viagra or to anti-impotency drug projects. But the report said the company decided on the project in early July during a Portfolio Review Workshop led by Herrling. It also quoted "reliable sources" as saying that Novartis planned to bring together 21 researchers from seven different laboratories to work on the project full time.

To: BigKNY3 who wrote (6097)	10/18/1998 5:26:00 PM
From: HiSpeed	Read Replies (1) \| Respond to of 9523

Cramer's (from TSC) take on the drug sector: "What doesn't work? If you think the Fed is going to ease aggressively, as I do, the drugs don't work. At all. Nor do the foods. If they rally, it will only be because the economy is even worse than we thought, but I just think the Fed will simply ease more aggressively, making these painful to own" I'm not sure what to make of that...comments anyone? thestreet.com (if not a member, sign up for the free trial period-lots of great writers)